31-45 of 126
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
Richard E. Pratley, MD
New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
NephrologyNew Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
prof. Hiddo Heerspink
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
NephrologyThe Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Pediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
On the Frontlines of PsoriasisPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
Charles Turck, PharmD, BCPS, BCCCP
Amy Paller, MS, MD
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Stephen Wong, PhD
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Ryan Quigley
- advertisement
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's RoundtableObesity and Cancer Screening: National Trends and Disparities Revealed
Vance Albaugh, MD, PhD
Obesity and Respiratory Function: Understanding Mechanical and Functional Impacts
Clinician's RoundtableObesity and Respiratory Function: Understanding Mechanical and Functional Impacts
Sujith Cherian MD, FCCP, DAABIP
Real-World Effectiveness of Liraglutide for Obesity: Multicenter Data From Turkey
Clinician's RoundtableReal-World Effectiveness of Liraglutide for Obesity: Multicenter Data From Turkey
Ryan Quigley
Lifestyle Intervention and Bone Quality in Older Adults with Obesity
Clinician's RoundtableLifestyle Intervention and Bone Quality in Older Adults with Obesity
Identifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
Clinician's RoundtableIdentifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
Navigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Clinician's RoundtableNavigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Jaime Moore, MD
- advertisement
Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
EndocrinologyOptimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Advances in Osteoporosis Treatment: Exploring Drug and Non-Drug Interventions
On the Frontlines of OsteoporosisAdvances in Osteoporosis Treatment: Exploring Drug and Non-Drug Interventions
Ashley Baker, MSN, PMHNP
Jad Sfeir, MD, MS
Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
On the Frontlines of OsteoporosisManaging High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
Charles Turck, PharmD, BCPS, BCCCP
Bart Clarke, MD
